Objectives: Angiotensin II (AngII) generation in response to vascular injury has long been assumed to influence neointimal proliferation contributing to restenosis. This concept has been supported by evidence that ACE inhibition and AT receptor blockade 1 effectively limits restenosis in the rat. On the other hand, ACE inhibition has proven ineffective in clinical trails. The present study examines the response of the porcine coronary artery after angioplasty in vitro and compares the actions of an ACE inhibitor to AngII receptor antagonists. Methods and results: Captopril, an ACE inhibitor, and the AngII receptor antagonists, losartan and PD123319, were evaluated for their ability to attenuate neointimal proliferation in a porcine organ culture model of coronary restenosis. The neointima was significantly increased by 300% after angioplasty compared to non-angioplasty controls. The AT receptor antagonist, 1 25 losartan, produced a significant reduction in neointimal index at 10 mol / l, while its in vivo metabolite, EXP3174, reduced neointimal 26 25
Introduction
tomatic restenosis of the coronary artery and may therefore require a second or third treatment. Coronary heart disease is a leading cause of death in the Restenosis is the primary reason for the failure of industrialized world. While pharmacological agents such as angioplasty intervention and its development may be lipid lowering drugs, antiplatelet / antithrombotic agents attributed to four phenomena: (1) platelet aggregation and and vasodilators have provided some therapeutic benefits thrombus formation, (2) arterial recoil, (3) vascular refor patients with vascular disease, mechanical revascularimodelling and (4) neointimal proliferative response. Curzation remains the most effective approach for dealing rently, a number of therapies have been designed to deal with advanced lesions. Procedures such as coronary bypass with platelet aggregation, including treatment with heparin, or angioplasty (with or without stents), however, are costly.
aspirin and other antiplatelet factors [1] [2] [3] [4] . Although Although initially less expensive, angioplasty may double arterial recoil can be managed reasonably well by inserting or triple in cost as 30-50% of patients experience sympstents, the proliferative response is less well understood and, hence, has proved more difficult to treat. The proliferative response may be divided into four phases: (1) medial smooth muscle cell (SMC) prolifermuscle proliferation correlated closely with their ability to ation, which begins 24 h post injury, is associated with attenuate neointimal formation. SMC death as well as the release of basic fibroblast growth factor (FGF-2), angiotensin II (AngII) and a-adrenergic hormones, (2) migration of SMCs across the internal 2. Materials elastic lamina (IEL) to form a neointima involves platelet derived growth factor (PDGF), AngII, transforming growth Tissue culture medium (DMEM-high glucose), antibiotfactor (TGF)-b and FGF-2, (3) replication of SMCs in the ics, trypsin and multiwell culture dishes (Linbro) were neointima is stimulated by PDGF, AngII, TGF-b and obtained from ICN-Flow (Costa Mesa, CA, USA). insulin-like growth factor (IGF)-1 and (4) the vasculature Fetal bovine serum (FBS), antibiotic-antimycotic (1003 has an increased and prolonged responsiveness to growth 10 000 U / ml penicillin G, 10 000 mg / ml streptomycin factors such as TGF-b, FGF-2, AngII and PDGF [5] .
sulfate, 25 mg / ml amphotericin) and culture plates were Substantial interest in the role of AngII in neointimal purchased from Gibco (Grand Island, NY, USA). Superproliferation was fostered by the finding that ACE infrost Plus glass microscope slides were supplied by Fisher hibitors could attenuate neointimal development following Scientific (Nepean, ON, Canada). Insulin, pyruvate, transangioplasty in the rat [6] . Application of ACE inhibitors or ferrin, ascorbic acid, selenium, captopril, AngII and Cy3-AngII receptor antagonists in rabbit [7] , baboon [8] Pig hearts (size matched, 340-440 g, with the exception mechanism mediated by peptidases such as chymase of the experiment shown in Fig. 3b where the heart weight [17, 18] . Regardless of the source, it seems unequivocal was 490-660 g) were obtained from the local abattoir and that AngII does indeed play a role in promoting both transferred to the laboratory (on ice) within 30 min of hypertrophic and hyperplastic vascular SMC growth, and excision. Hearts were placed on ice and the LADCA (left local RAS activation has been implicated in the vascular anterior descending coronary artery) flushed with PBS response to injury. With respect to AngII receptors, the containing 103antibiotic-antimycotic (AB-AM). A stan-AT subtype is by far the best characterized and it is dard angioplasty catheter (2033.5 mm) was inserted into 1 responsible for the modulation of AngII-mediated vasoconthe coronary artery and passed along the LADCA distal to striction. The second major AngII receptor subtype (AT ) the first major bifurcation. The catheter was inflated to five 2 has a less well defined role, although a diverse array of atmospheres for 1 min. Control vessels were treated in an functions, such as development [19] , apoptosis [20] and identical manner with the exception of catheter insertion proliferation [21] , have been attributed to it. While transand inflation, and a similar 20-mm region of the LADCA genic knockouts of the AT receptor have been developed just distal to the first major branch was used. Each vessel 2 [22] , a physiological function for this receptor subtype was cut into four equal 5-mm segments, and one control or could not be discerned during fetal developmental.
catheter treated segment was randomly placed per culture The objective of this study was to determine whether an dish. Dishes were incubated at 378C, 5% CO in 20% 2 ACE inhibitor and / or AngII receptor antagonists were able FBS-DMEM-103AB-AM. Media and drugs were to directly reduce neointimal proliferation associated with changed every second day with the concentration of ABre / stenosis, independent of hemodynamic reduction of AM reduced to 13 over days 6-14. vascular wall stress. This aim was accomplished by using a modified in vitro porcine model of coronary stenosis after 2.2. Morphometric determinations balloon angioplasty [23] to examine the effects of AngII receptor antagonists and ACE inhibition on neointimal Vessel segments were removed from culture on the formation. Our findings suggest that the ability of AngII fourteenth day, placed in formalin or Streck fixative receptor antagonists to inhibit AngII mediated smooth (Streck, Omaha, NE, USA) and passed through a graded ethanol series prior to embedding in JB-4 (Polysciences, the Bonferroni (versus control) method was used to Warrington, PA, USA). Embedding in resin is necessary compare treatment means versus non-angioplasty and because the delicate neointima is often lost in standard angioplasty controls (significance was set at P,0.05). paraffin or cryosectioned material. The tissue blocks were faced to remove 1.5 mm of the cut surface of the vessel to avoid artifacts generated by the cut site. Sections of 1-2 3. Results mm were stained with Lee's methylene blue, and photomicrographs taken using an Olympus BH2 microscope.
3.1. Neointimal proliferation in response to balloon Photographs were scanned with an HP Scan Jet at 300 dpi, angioplasty in vitro and imported into SIGMASCAN / IMAGE software (Jandel Scientific) for morphometric determination of intimal and
Incubation of porcine coronary artery segments in vitro medial areas. The neointimal index represents a ratio of resulted in the development of a neointima consisting of neointimal area to medial area transformed to a percent of 2-3 cell layers associated with a compact extracellular non-angioplasty treated control [(treated group neointimal / matrix and few disruptions in the IEL (Fig. 1A and A9 ). medial area) /(control group intimal / medial area)]3100
This progression occurred in the presence of a single layer (n56-8 per treatment).
of endothelial cells, although irregularity of staining for von Willebrand's factor suggested that the process of 2.3. Smooth muscle cell culture culture either resulted in some endothelial cell loss or caused a functional change in these cells (data not shown). Primary cultures of VSMC were prepared by migration A 14-day culture period following balloon catheter from free-floating explants of porcine coronary artery inflation within the vessels produced a significantly greater segments [24] . Following 5-10 days in culture, cells began neointima compared to non-catheter treated vessels ( Quantification of the neointimal index indicated there was confluent (1-2 days). The growth medium was removed an increase of .300% relative to non-injured control and replaced with DMEM supplemented with 5 mg / ml vessels (Fig. 2) . Distinguishing features of this neointima 29 24 transferrin, 1?10 mol / l selenium, 2?10 mol / l ascorinclude numerous breaks in the IEL, extensive extracellu- Although preparation of the vessel segments for culture once with ethanol and the radioactivity determined by causes a cut site injury, the neointima produced during the liquid scintillation counting. In a parallel experiment, cells healing process, which can be seen in longitudinal section were treated in the absence of radiolabeled thymidine for (data not shown), does not extend more than 1 mm from 96 h, harvested by trypsinization and total cell number the edge. Furthermore, this region was carefully removed measured using a haemocytometer. A third triplicate set of prior to morphometric analysis. cells was treated with AngII6receptor antagonists in the presence of 1 mmol / l BrdU. Cells were fixed with 3.2. Effect of ACE inhibition on neointimal proliferation methanol 96 h post-treatment and processed for immunocytochemical staining as outlined by the manufacturer.
Administration of the ACE inhibitor captopril at doses 26 of 10 mol / l in rats has proven effective in reducing 2.4. Data and statistical analysis neointimal proliferation post angioplasty [6], however, ACE inhibitors have proven less effective in reducing Morphometric, scintillation counts and cell number data neointimal proliferation in non-rodent systems [25, 26] . In were quantified and graphically represented as order to measure the efficacy of captopril on inhibiting means6S.E.M. Data were analyzed using ANOVA while neointimal proliferation in the in vitro porcine model we 10 mol / l produced a dose-dependent reduction in neointimal proliferation (Fig. 3a) . The concentration of losartan required to reduce neointimal proliferation to 25 control levels was high, 10 mol / l. In fact, losartan 25 treatment at 10 mol / l produced a 69% reduction in the neointimal index compared with angioplasty controls. At 26 27 more pharmacological doses (10 and 10 mol / l), losartan reduced intimal proliferation by 49 and 41%, respectively, compared to angioplasty alone; however, the almost 50% reductions in neointimal index were not statistically significant. The lack of statistical significance is, in part, a consequence of the variability that exists in response to angioplasty (see Fig. 1C and C9) which reduces the statistical power and thereby the ability to resolve differences between group means. Nevertheless, visual inspection demonstrates that differences between the treatments can be readily distinguished. The significant reduc- significantly different from losartan at 10 mol / l, confirming that indeed EXP3174 is an order of magnitude 26 chose a dose of 10 mol / l. It was observed that, rather more potent than losartan. Interestingly, higher concen-25 than reducing neointimal area, captopril increased the trations of EXP3174 (e.g. 10 mol / l) produced a neoinmagnitude of neointimal proliferation 200% beyond baltima not significantly different from angioplasty treatment loon injured vessels (Fig. 2, Table 1 ). The elevation in alone (Fig. 3b) , suggesting a possible agonist effect or neointimal index obtained with captopril treatment may cross-reaction with other receptors at high doses. represent either an increase in intimal area or a reduction Blockade of the AT receptor using PD123319 over the 2 27 25 in medial area. Table 1 demonstrates, however, that range 10 to 10 mol / l produced a dose-dependent captopril treatment leads to a profound increase in intimal reduction in neointimal proliferation ( AngII, or at least its mode of generation, was brought into high concentrations of PD123319 (10 mol / l) produced a question. Therefore, to circumvent the question of mechaneointimal index that was not significantly different from nism of AngII generation we opted to target an AngII control and represented a 67% reduction in neointimal mediated proliferative response via AT and AT specific index compared with angioplasty treatment alone. Ad- neointimal proliferation compare the response of 10 mol / l losartan which produced a 41% reduction in neointimal index, whereas LADCA culture in the presence of the AT receptor PD123319 over the same concentration range produced no 1 27 antagonist losartan over the concentration range 10 to intimal reduction. Losartan and PD123319, however, per- significant differences were observed in comparisons between angioplasty and non-angioplasty groups (1), non-angioplasty and losartan (10 , 10 25 mol / l) treatment after angioplasty (1), and angioplasty with or without losartan (10 mol / l) treatment (*). (b) With EXP3174, the active metabolite of losartan, significant differences were realized between non-angioplasty control, and angioplasty plus EXP3174 treatment (*), as well as between angioplasty and angioplasty plus EXP3174 treated samples (1). Symbols: 1, without angioplasty control versus treatment (P,0.05); *, angioplasty control versus treatment (P,0.05). Differences in control groups between the experiment illustrated in (a) and (b) reflect variations in heart weight and number of vessels per treatment (a) n5628, mean heart weight 340-440 g, (b) n54 per group, mean heart weight 490-660 g. 25 26 formed equally well in the range 10 -10 mol / l, cultures of quiescent porcine coronary artery SMCs which 26 although there was a apparent reduction in both neointimal had been treated with 10 mol / l AngII. Either losartan or and medial proliferation produced by these drugs (Table  PD123319 blocked the stimulation of bromodeoxyuridine 2).
incorporation by AngII when added individually to the cultures (Fig. 5) . Confirmation that this effect was coupled 3.4. Effect of AngII receptor blockade on smooth muscle to an inhibition of DNA synthesis was obtained by 3 cell proliferation measuring [ H]thymidine incorporation in the presence of losartan or PD123319 (Fig. 6 ). These data indicate that
25
To establish whether the AngII receptor antagonists losartan or PD123319 (10 mol / l) interfere with the could directly inhibit porcine vascular SMC proliferation, action of AngII on SMC proliferation resulting in a 35 and losartan and PD123319 were added to explant-derived 30% reduction in DNA synthesis, respectively, compared onary artery is expressed as the neointimal index (n56-8, mean heart plus losartan (10 mol / l), and AngII plus PD123319 (10 mol / l) to weight 340-440 g). Non-injured vessels have a significantly lower index quiescent SMCs. Statistically significant differences are indicated for of proliferation (1) compared to angioplasty-treated coronary explants.
control versus AngII treatment (1, P,0.05), and AngII treatment alone
Angioplasty plus the administration of 10 mol / l PD123319 produced a versus AngII treated with antagonist (*, P,0.05). Control5quiescent neointimal index that was significantly lower than the angioplasty treated cells without AngII stimulation. 26 27 control group (*). Lower concentrations of PD123319 (10 mol / l, 10 mol / l) resulted in neointimal proliferation significantly greater than nonangioplasty control levels (1). Symbols: 1, without angioplasty control versus treatment (P,0.05); *, angioplasty control versus treatment (P, 0.05). after balloon injury (Fig. 1B and B9, Fig. 2) . The ability to reproducibly detect changes in neointimal size indicated that this model was a suitable tool for evaluating the role of AngII as a mediator of smooth muscle cell proliferation in response to injury. In addition, several vascular changes that were detectable in the vessel segments after injury were useful for full characterization of the response. These included: (1) increased intimal thickening, (2) disruption of the internal elastic lamina, (3) abundant ECM deposition, (4) accumulation of SMC in the intimal region and (5) focal subintimal / medial cell loss and associated fibrosis (Fig. 1) . Systemic and local vascular AngII has two biological functions, since it operates to both maintain and increase blood pressure as well as to stimulate VSMC growth [29] [30] [31] . It has become evident that these functions are release of growth factors such as PDGF and TGF-b [5, [32] [33] [34] [35] , as well as hypertrophic agents such as endothelin [36] . to AngII treated controls. These values represent an A direct role for AngII in neointimal proliferation was inhibition of the stimulation produced by AngII of |100% indicated by Laport and Escher [37] (Fig. 7) . porcine [9,10] and human [24, 25] systems have not found This value represents a 71% inhibition of the increase in ACE inhibitors effective in reducing neointimal prolifercell number attributed to AngII.
ation. Using the present model, which eliminated the variables of vascular wall tension and blood flow (among others), we found that the ACE inhibitor captopril in fact 4. Discussion increased neointimal area by .200%. A comparable effect has not been observed in vivo, suggesting other factors not To address the issue of whether local production of active in the organ culture system are important elements AngII by SMCs is sufficient to mediate restenosis, we of the vascular response exclusive of the smooth muscle employed an organ culture model of stenosis following component. In order to reconcile this conflict, one may balloon angioplasty. The vascular responses observed in consider the possibility that the vasodilatory effects (reducthis system reflect the reaction of SMCs in the absence of tion in wall tension) of ACE inhibitors in vivo may offset a infiltrating cells, pressure, flow, and recolonization by wall stress-dependent proliferative effect. A second considendothelial cells. The organ culture model thus provides a eration is that clinical studies, such as the recently comunique opportunity to examine SMC-derived factors.
pleted MERCATOR [24] and MARCATOR [25] trials, Proliferation leading to an additional two to three layers examining ACE inhibitor efficacy in reducing restenosis of intimal cells was observed in the non-injured control utilized angiography as an index of restenosis. Although vessel (Fig. 1A and A9) . As reported by Voisard et al. [23] , angiography provides anatomical evidence for the developwho used a coronary artery organ culture model similar to ment of a lesion, it cannot identify the mechanism responthe one employed in this investigation, as well as Koo and sible for its formation. Only a complete histological Gotlieb [28] using a porcine aortic organ culture system, examination could distinguish, for example, between reformation of a limited neointima appears to be a normal duced neointimal proliferation and compensatory vasodiresponse of vessels placed into culture even in the presence latation. Indeed, a number of recent reports [15, 16, 38 ,39] of an apparently intact endothelial layer. Nevertheless, examining the mechanism of ACE inhibitor action in significantly greater neointimal proliferation was observed congestive heart failure support the hypothesis that ACE inhibitor action may be largely mediated by an accumulatage of the in vitro culture model), demonstrated that high 25 tion of bradykinin as much as or more than reductions in concentrations of losartan (10 mol / l) significantly atAngII. In fact, bradykinin has been shown to induce tenuated neointimal proliferation. Is this a real effect or is 25 proliferation in a number of cell types [40] [41] [42] , however, losartan at 10 mol / l toxic? Data derived from treatment this has yet to be demonstrated specifically in SMCs. A with the more active losartan metabolite EXP3174 refurther alternative is that there exist species-dependent vealed that lower concentrations are required to attenuate 25 variation in the pathways responsible for generating tissueproliferation, and even higher concentrations (10 mol / l) derived AngII. Okonishi et al. [43] has put forth the restore intimal proliferation to angioplasty-treated control hypothesis that AngII may be generated locally via a levels. These results suggest either a partial agonist effect chymase-dependent mechanism. If this is true, ACE inor cross reactivity with other receptors at high concenhibitors would have less effect on local AngII concentrations, and clearly indicate the absence of toxicity. trations yet still reduce systemic AngII and elevate sysIt is interesting that many groups [10, 30, 31] , in an effort temic bradykinin levels. Danser et al. [44] , however, have to attenuate vascular proliferation, have administered AT 1 recently shown using isolated perfused porcine coronary receptor antagonists at concentrations that are effective in and carotid arteries (a preparation similar to ours) that the normalizing or reducing blood pressure. This practice bulk of AngII generation is via a mechanism that is assumes that all effects mediated by the AT receptor are 1 abrogated by administration of the ACE inhibitor captopril. pressure dependent, and precludes the following alterThese data do not take into account the contributions of natives: (1) trophic effects may be mediated by AT 1 blood cells which infiltrate injured tissue almost immedipressure-dependent and pressure-independent mechanisms, ately and are known to be a potent source of proteolytic where pressure-independent mechanisms may require enzymes, including chymases [45] . The current literature greater receptor occupancy than would be required to suggests that the majority of AngII production in rat occurs normalized blood pressure and (2) changes in receptor via an ACE-dependent mechanism [43, 46, 47] . In other density at a local / regional injury site may cause these species such as dog, there appears to be a 60:40 split areas to become more or less sensitive to administration of between ACE and ACE-independent mechanisms a receptor antagonist than the non-injured vasculature. The [17, 47, 48] . With respect to humans, the literature suggests latter point is supported by evidence showing vascular local AngII production may involve a chymase-dependent tissue that has been injured does not have the same pathway [47, 49, 50] . It is important to realize, however, receptor profile as uninjured tissue. Specifically, it was that consensus on this point has not been reached. For demonstrated that, although AT receptor mRNA expres-1 example, the data of Zisman et al. [51] supports the sion is elevated upon administration of losartan, receptor existence of a local ACE-dependent pathway, while the binding is actually reduced in the kidney [53] . As such, data of Wolny et al. [50] as well as recent work from drug dosages should be tailored to effect a change in action Balcells et al. [47] , point to a serine protease, perhaps at the site of injury rather than systemic effects. If this chymase, as important in local AngII production in precludes the use of systemic administration due to humans. Interestingly, it is possible that the presence of systemic toxicity, then local delivery of drugs with a infiltrating cells, which are capable of converting AngI to shorter half-life should be sought. AngII in tissue preparations, or methodological differences
The response to injury in the model is not uniform, as as outlined by Balcells and coworkers [47, 52] could demonstrated in Fig. 1 and by the variability in neointimal explain some of these apparently contradictory results. It is index. This is very similar to the clinical setting where therefore possible that AngII produced in response to only 30-50% of patients develop restenosis as defined by vascular injury could be derived from both ACE-dependent angiography. Nevertheless, it is realized that all patients and ACE-independent pathways. undergo restenosis to some degree. In the statistical Once the effect of ACE inhibition was realized, it analysis of our data, we have chosen not to partition high became important to establish if direct blockade of AngII responders from low responders since we are at present receptors, independent of the effects on wall stress reducunable to do this clinically prior to treatment. This tion, is able to attenuate neointimal proliferation in relimitation in the paradigm may actually be an asset in that sponse to injury. As indicated in the results, there was a it closely represents the clinical situation of variable concentration-dependent reduction in neointimal index restenosis in both rate and extent. Our cell culture studies, brought about by AT or AT receptor blockade (Figs. 3 in which the experimental conditions are more uniform, which examined the vascular response to a broader confibrosis in hypertensive rats [30] , has been obtained with centration range of receptor antagonist (one major advanboth local administration (at 1 mg / kg / day) and high on the concentration used [59, 60] . This finding may AT receptors at high concentrations is effective in at- results, we anticipate that local delivery of high con- the proliferative element of stenosis following angioplasty. will completely abrogate proliferative restenosis, as we 
